Chemokine receptor 2 antagonist CCX140-B in Phase 2 for type 2 diabetes

被引：0
|
作者：
Sullivan, T. [1 ]
Miao, S. [1 ]
Berahovich, R. [1 ]
Zhao, N. [1 ]
Ungashe, S. [1 ]
Johnson, D. [1 ]
Bekker, P. [1 ]
Jean, J. [1 ]
Schall, T. J. [1 ]
机构：
[1] ChemoCentryx Inc, Mountain View, CA USA
来源：
DIABETOLOGIA | 2010年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
883
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Evaluation of a novel chemokine receptor 2 (CCR2)-antagonist in painful diabetic polyneuropathy
    Kalliomaki, Jarkko
    Jonzon, Bror
    Huizar, Karin
    O'Malley, Michael
    Andersson, Anita
    Simpson, David M.
    SCANDINAVIAN JOURNAL OF PAIN, 2013, 4 (02) : 77 - 83
  • [22] THE CCR2 ANTAGONIST CCX140 IMPROVES RENAL FUNCTION IN TWO TYPES OF DIABETIC MICE EXPRESSING HUMAN CCR2
    Powers, Jay
    Sullivan, Timothy
    Miao, Zhenhua
    Berahovich, Rob
    Ertl, Linda
    Walters, Matthew
    Miao, Shichang
    Jaen, Juan
    Schall, Thomas
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 51 - 51
  • [23] PHARMACOLOGICAL AND MOLECULAR ACTIONS OF THE BRADYKININ-B2 RECEPTOR ANTAGONIST, HOE 140, IN THE RAT UTERUS
    LIEBMANN, C
    NAWRATH, S
    LUDWIG, B
    PAEGELOW, I
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 235 (2-3) : 183 - 188
  • [24] A-348441: A liver-selective glucocorticoid receptor antagonist for type 2 diabetes
    Jacobson, P
    Von Geldern, T
    Ohman, L
    Zinker, B
    Wilcox, D
    Nguyen, P
    Mika, A
    Edgerton, D
    Cherrington, A
    Fowlkes, D
    Opgenorth, T
    DIABETES, 2003, 52 : A340 - A341
  • [25] Sustained Effects of Interleukin-1 Receptor Antagonist Treatment in Type 2 Diabetes
    Larsen, Claus M.
    Faulenbach, Mirjam
    Vaag, Allan
    Ehses, Jan A.
    Donath, Marc Y.
    Mandrup-Poulsen, Thomas
    DIABETES CARE, 2009, 32 (09) : 1663 - 1668
  • [26] Interleukin-1 Receptor Antagonist: A New Therapy for Type 2 Diabetes Mellitus
    Akash, Muhammad Sajid Hamid
    Shen, Qi
    Rehman, Kanwal
    Chen, Shuqing
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 101 (05) : 1647 - 1658
  • [27] Effect of antagonist of B-2 bradykinin receptor in experimental diabetes in rats.
    Ortiz, MA
    Xaus, C
    Rosello, J
    Pou, JM
    DIABETOLOGIA, 1996, 39 : 368 - 368
  • [28] Pharmacokinetics of YJC-10592, a novel chemokine receptor 2 (CCR-2) antagonist, in rats
    Eun Sin Du
    Hong Sik Moon
    Soo-Jeong Lim
    So Hee Kim
    Archives of Pharmacal Research, 2016, 39 : 833 - 842
  • [29] Pharmacokinetics of YJC-10592, a novel chemokine receptor 2 (CCR-2) antagonist, in rats
    Du, Eun Sin
    Moon, Hong Sik
    Lim, Soo-Jeong
    Kim, So Hee
    ARCHIVES OF PHARMACAL RESEARCH, 2016, 39 (06) : 833 - 842
  • [30] Chemokine receptor CCR1 antagonist CCX354-C treatment for rheumatoid arthritis: CARAT-2, a randomised, placebo controlled clinical trial
    Tak, Paul P.
    Balanescu, Andra
    Tseluyko, Vira
    Bojin, Silvia
    Drescher, Edit
    Dairaghi, Dan
    Miao, Shichang
    Marchesin, Vittorio
    Jaen, Juan
    Schall, Thomas J.
    Bekker, Pirow
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (03) : 337 - 344
12345